<DOC>
	<DOCNO>NCT00761787</DOCNO>
	<brief_summary>The Cardiac Allograft Rejection Gene Expression Observational ( CARGO ) II Study design provide independent evidence clinical performance non-invasive AlloMap test . Sensitive detection cardiac allograft rejection dysfunction basis successful recipient management . The CARGO II Study assess correlation presence absence acute cellular rejection determine examination endomyocardial biopsy specimen result AlloMap Test . Of 17 participate transplant center , 4 North America 13 Europe .</brief_summary>
	<brief_title>Cardiac Allograft Rejection Gene Expression Observational ( CARGO ) II STUDY</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<criteria>New exist allograft recipient All patient ( age â‰¥ 18years ) receiving posttransplant care enrol center Concurrent enrollment doubleblind drug trial ( immunosuppressive drug ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>allograft</keyword>
	<keyword>rejection</keyword>
	<keyword>biopsy</keyword>
	<keyword>gene</keyword>
	<keyword>expression</keyword>
	<keyword>cardiology</keyword>
	<keyword>heart</keyword>
	<keyword>transplant</keyword>
</DOC>